FDA Investigator Sonya M Lambkin
Sonya M Lambkin has conducted inspections on 49 sites in 1 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sonya M Lambkin:
Alanna L Mussawwir Bias,
Alexandra A Carrico,
Amina Bashir,
Anthony R Petriella,
Armando Morales,
Art O Czabaniuk,
Barbara A Rusin,
Bei Y He,
Bleta Vuniqi,
Brian M Campbell,
Brian P Putz,
Brittany A Mckenzie,
Byron Ho, DVM,
Carolyn J Oyster,
Cathie S Marshall,
Christi L Bellmore,
Christina Eggleston,
Christine J Watts,
Courtney E Hillier,
Crystal M Young Lewis,
Daniel J Gorski,
Danny Tuntevski,
David A Paterson,
Deanna L Lampley,
Dennis R Downer,
Donald W Myrick,
Dylan C Grippi,
Elizabeth J Rigoni,
Eric E Joneson,
Erin M Miller,
Gary Durbiel Goldner,
Geneve M Parks,
Hassan Ali,
Hokenson,
Jacob A Clark,
Jankowski,
John N Woodall,
Joohi Castelvetere,
Joseph R Haynes,
Joseph R Strelnik,
Judith A Jankowski,
Julia A Avery,
Katharine M Oaks,
Kathleen M Adams,
Kathryn A Cutajar,
Kathryn A Guardiola,
Kathryn G Brown,
Kristina Mezin,
Kristina Nastovski,
Lauren E Burke,
Lauren E Sexton,
Linda S Jozefiak,
Lisa J Joseph,
Lisa J Renick,
Lisa M Thursam,
LTJG Aaron B Otis,
Margaret N Persich,
Marlon K Turner,
Martin R Vowell,
Matthew J Gretkierewicz,
Megan C Amye,
Megan C Spencer,
Michael A Moutray,
Michele L Forster, PhD,
Michelle L Jones,
Mikhail V Ovanesov, PhD,
Neali H Lucas,
Nelson,
Nicholas E Boyd,
Owens,
Patrick E Gainer,
Rasha Bamieh,
Renick,
Richard T Riggie,
Robert P Whisenant,
Roger A Hartman,
Rohn R Robertson,
Ryan J Benedict,
Sargum C Sood,
Theodore N Sietsema,
Tonnie L Carter,
Tracey L Siebesma,
Twana R Chandler,
Vesa Vuniqi,
Victoria A Murray,
Wendy M Stark,
William G Craig
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more